Log in to save to my catalogue

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68371448

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

About this item

Full title

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

Publisher

New York, NY: Nature Publishing

Journal title

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.67-77

Language

English

Formats

Publication information

Publisher

New York, NY: Nature Publishing

More information

Scope and Contents

Contents

Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack of typical D(2) dopamine receptor antagonist properties. Whether aripiprazole is a typical D(2) partial agonist, or a functionally selective D(2) ligand, remains controversial (eg D(2)-mediated inhibition of adenylate cycl...

Alternative Titles

Full title

Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68371448

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68371448

Other Identifiers

ISSN

0893-133X

E-ISSN

1740-634X

DOI

10.1038/sj.npp.1301071

How to access this item